Terms: = Ovarian cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
4 results:
1. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
[TBL] [Abstract] [Full Text] [Related]
2. Inherited gynaecological cancers.
George A
Curr Opin Oncol; 2018 Sep; 30(5):317-322. PubMed ID: 30036195
[TBL] [Abstract] [Full Text] [Related]
3. Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer.
Ino K
Curr Opin Obstet Gynecol; 2011 Feb; 23(1):13-8. PubMed ID: 20930628
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years' experience in the Kinki District of Japan (1990-2006).
Kokawa K; Mikami Y; Sakata H; Oki N; Tanakas T; Yamazaki M; Nakata Y; Umesaki N
Eur J Gynaecol Oncol; 2009; 30(2):155-61. PubMed ID: 19480244
[TBL] [Abstract] [Full Text] [Related]
